| Multi-disciplinary approach for drug and gene delivery systems to the brain NB Ndemazie, A Inkoom, EF Morfaw, T Smith, M Aghimien, D Ebesoh, ... AAPS PharmSciTech 23, 1-21, 2022 | 26 | 2022 |
| Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models A Inkoom, N Ndemazie, K Affram, T Smith, X Zhu, P Underwood, ... International journal of pharmaceutics: X 2, 100056, 2020 | 15 | 2020 |
| Evaluation of anticancer activity of Zhubech, a New 5-FU analog liposomal formulation, against pancreatic cancer NB Ndemazie, R Bulusu, XY Zhu, EK Frimpong, A Inkoom, J Okoro, ... International Journal of Molecular Sciences 24 (5), 4288, 2023 | 5 | 2023 |
| Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer A Inkoom, NB Ndemazie, T Smith, E Frimpong, R Bulusu, R Poku, X Zhu, ... BMC cancer 23 (1), 435, 2023 | 3 | 2023 |
| Synthesis, characterization, and anticancer evaluation of 1, 3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer NB Ndemazie, A Inkoom, D Ebesoh, R Bulusu, E Frimpong, J Trevino, ... BMC cancer 22 (1), 1345, 2022 | 3 | 2022 |
| Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-derived xenograft model A Inkoom, N Ndemazie, T Smith, E Frimpong, R Bulusu, R Poku, X Zhu, ... | 1 | 2022 |
| Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer E Frimpong, R Bulusu, J Okoro, A Inkoom, N Ndemazie, S Rogers, X Zhu, ... European Journal of Pharmaceutical Sciences 196, 106754, 2024 | | 2024 |
| Synthesis and biological evaluation of novel 5-FU analogs against pancreatic cancer E Frimpong, R Bulusu, J Okoro, A Inkoom, N Ndemazie, S Rogers, X Zhu, ... Cancer Research 84 (6_Supplement), 1825-1825, 2024 | | 2024 |
| Development of Novel Pyrimidine Nucleosides as Potential Anticancer Agents: Synthesis, Characterization, and Invitro Evaluation against pancreatic cancer E Frimpong, R Bulusu, J Okoro, A Inkoom, N Ndemazie, S Rogers, X Zhu, ... | | 2023 |
| Characterization and evaluation of modified 5-fluorouracil loaded liposomal nanoparticle on pancreatic and colorectal cancer cell lines R Bulusu, NB Ndemazie, EK Frimpong, A Inkoom, JC Okoro, XY Zhu Cancer Research 83 (7_Supplement), 839-839, 2023 | | 2023 |
| Biological evaluation of novel stearoyl gemcitabine nanoparticles in primary pancreatic cancer cells and PDX mice tumor models EK Frimpong, A Inkoom, NB Ndemazie, R Bulusu, JC Okoro, B Han, ... Cancer Research 83 (7_Supplement), 816-816, 2023 | | 2023 |
| Optimizing Gemcitabine efficacy through chemical modification for the treatment of pancreatic cancer using PDX mouse model A Inkoom, E Agyare, NB Ndemazie, T Smith, B Han, JT Trevino Cancer Research 82 (12_Supplement), 1746-1746, 2022 | | 2022 |
| Synthesis, Characterization, and Biological Evaluation of Novel Stearoyl Gemcitabine Nanoparticles for Treating Pancreatic Cancer in Patient-Derived Xenograft Mouse Models with … A Inkoom Florida Agricultural and Mechanical University, 2022 | | 2022 |
| Abstract PO-047: Optimizing the efficacy of 5-FU as a chemotherapeutic agent in advanced pancreatic ductal adenocarcinoma (PDAC) using MIAPaCa-2 and PANC-1 cells NB Ndemazie, A Inkoom, XY Zhu, E Agyare Cancer Research 81 (22_Supplement), PO-047-PO-047, 2021 | | 2021 |
| Abstract PO-108: Evaluation of antitumor activity of modified-gemcitabine solid-lipid nanoparticle in pancreatic pdx models E Agyare, T Smith, A Inkoom, B Han, J Trevino, NB Ndemazie Cancer Research 81 (22_Supplement), PO-108-PO-108, 2021 | | 2021 |
| Evaluation of antitumor activity of modified-gemcitabine solid-lipid nanoparticle in pancreatic pdx models. E Agyare, T Smith, A Inkoom, B Han, J Trevino, NB Ndemazie CANCER RESEARCH 81 (22), 73-74, 2021 | | 2021 |
| Optimizing the efficacy of 5-FU as a chemotherapeutic agent in advanced pancreatic ductal adenocarcinoma (PDAC) using MIAPaCa-2 and PANC-1 cells. B Ndemazie, A Inkoom, XY Zhu, E Agyare CANCER RESEARCH 81 (22), 32-33, 2021 | | 2021 |
| Enhancing efficacy of modified-gemcitabine nanoparticles in pancreatic PDX model T King, T Smith, K Affram, J Trevino, B Han, E Agyare, A Inkoom CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 29 (6), 2020 | | 2020 |
| Abstract D050: Enhancing efficacy of modified-gemcitabine nanoparticles in pancreatic PDX model T King, T Smith, K Affram, J Trevino, B Han, E Agyare, A Inkoom Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_2), D050-D050, 2020 | | 2020 |
Bo HanUniversity of southern California在 usc.edu 的电子邮件经过验证
Bo HanUniversity of southern California在 usc.edu 的电子邮件经过验证